Dr Reddy's falls on concerns Q3 results may miss estimates

RELATED QUOTES

SymbolPriceChange
DRREDDY.NS3,186.40-25.30
SNI71.72-1.22

Reuters Market Eye - Shares in Dr Reddy's Laboratories(NSI:DRREDDY.NS - News) fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day.

Margins are also expected to see significant erosion, several dealers add.

Dr Reddy's could miss consensus earnings per share (EPS) estimates by 6 percent in the October-December quarter, according to Thomson Reuters StarMine SmartEstimate data, which measures the forecasts from top-ranked analysts against wider forecasts. * StarMine SmartEstimate suggests EPS for the quarter ending December at 26.03 rupees compared with mean estimate of 27.89 rupees.

(Reporting by Abhishek Vishnoi)

Market Data

  • Currencies
    Currencies
    NamePriceChange% Chg
    1.2575+0.0004+0.03%
    GBPUSD=X
    1.1904+0.0058+0.49%
    GBPEUR=X
    144.9700+1.58+1.10%
    GBPJPY=X
  • Commodities
    Commodities
    NamePriceChange% Chg
    50.46-0.01-0.02%
    BZF17.NYM
    1,158.40-11.40-0.97%
    GCZ16.CMX
    16.82-0.20-1.20%
    SIZ16.CMX
    2.64+0.03+0.95%
    HGZ16.CMX

TOP TRADING PROVIDER

  • Trade now

    Trade now

    Create account for free with the No.1 spread betting and CFD provider. Losses can exceed deposits. More »